For all the arm chair scientists out there.. read this on the Catabasis P2..
Why it was never considered SOC and why the mode of action was TOO DOWNSTREAM to be taken seriously way before P3 was released.
ATL1102 goes right to the UPSTREAM beginning of disease progression.
https://www.clinicaltrialsarena.com/comment/catabasis-phase-iii-edasalonexent-soc-swap-for-steroids/
Enough said.
For all the arm chair scientists out there.. read this on the...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $47.27K | 463.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 319942 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 86442 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |